XML 48 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Subsequent Events (Details) - USD ($)
1 Months Ended
Oct. 02, 2017
Nov. 30, 2017
Sep. 30, 2017
Jan. 31, 2017
Dec. 31, 2016
Subsequent Events (Textual)          
Share Price     $ 0.20   $ 0.30
Common stock, shares issued     44,257,342 217,391 35,570,157
Subsequent Event [Member] | Robert Kalkstein [Member]          
Subsequent Events (Textual)          
Consulting agreement, description On October 2, 2017, Robert Kalkstein was appointed as the Chief Financial Officer of Immudyne, Inc. The Company entered into a consulting agreement with Mr. Kalkstein, which provides, among other things, for a fee of $2,750 per month through December 2017, $5,000 per month between January 2018 and March 2018 and $7,500 per month between April 2018 and September 2018.        
Purchase of common stock 500,000        
Share Price $ 0.40        
Subsequent Event [Member] | Michael T. Bornstein [Member]          
Subsequent Events (Textual)          
Purchase of common stock 100,000        
Option vesting, description
As part of the compensation, the Company issued a ten year, fully vested option to purchase 100,000 shares of common stock at an exercise price of $0.35 per share. In addition, the Company issued ten year options that vest upon the Company achieving pre-tax earnings benchmarks between $4,000,000 and $7,000,000. The exercise price for the options are $0.25 and $0.35 per share.
       
Common stock, shares issued   135,721      
Warrants issued   67,861      
Noncontrolling interest   $ 31,216